Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Receptor-independent
100%
Cardiac Fibroblasts
100%
Peroxisome Proliferator-activated Receptor
100%
Thiazolidinediones
100%
Myocardial Remodeling
30%
Antiproliferative Activity
20%
14-prostaglandin J2
20%
Myofibroblast Proliferation
20%
Immunoblotting
10%
Type 2 Diabetic Patients
10%
Receptor Antagonist
10%
Drug Class
10%
Cytoskeleton
10%
Cell Migration
10%
Cell number
10%
Beneficial Effects
10%
Vasculature
10%
Concentration-dependent
10%
Cell Invasion
10%
Matrix metalloproteinase-2 (MMP-2)
10%
Receptor Activation
10%
Ligand-receptor Binding
10%
Insulin Resistance
10%
GW9662
10%
Proliferating Cell nuclear Antigen
10%
Rosiglitazone
10%
Gelatin Zymography
10%
T0070907
10%
Fluorescent Confocal Microscopy
10%
Ciglitazone
10%
Boyden Chamber Assay
10%
Remodeling Process
10%
Matrigel
10%
Troglitazone
10%
Rhodamine-phalloidin
10%
Cellular Expression
10%
Peroxisome Proliferator-activated Receptor Agonists
10%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Thiazolidinedione
100%
Prostaglandin J2
20%
Western Blot
10%
Confocal Microscopy
10%
Gelatin
10%
Gelatinase A
10%
Actin
10%
Rosiglitazone
10%
Ciglitazone
10%
Antiproliferative Activity
10%
Matrigel
10%
Rhodamine
10%
Troglitazone
10%
2 Chloro 5 Nitrobenzanilide
10%
Insulin Resistance
10%
2 Chloro 5 Nitro N (4 Pyridyl)benzamide
10%
Cycline
10%
Peroxisome Proliferator Activated Receptor Antagonist
10%
PPAR Agonist
10%
Phalloidin
10%